The landscape of metabolic brain alterations in Alzheimer's disease-Reference-Cited by-同舟云学术

The landscape of metabolic brain alterations in Alzheimer's disease

Published:2022-07-13 Issue:3 Volume:19 Page:980-998
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Batra Richa¹,Arnold Matthias²³,Wörheide Maria A.³,Allen Mariet⁴,Wang Xue⁵,Blach Colette²,Levey Allan I.⁶,Seyfried Nicholas T.⁷,Ertekin‐Taner Nilüfer⁴⁸,Bennett David A.⁹,Kastenmüller Gabi³,Kaddurah‐Daouk Rima F.¹⁰,Krumsiek Jan¹^ORCID,

Affiliation:

1. Department of Physiology and Biophysics Institute for Computational Biomedicine Englander Institute for Precision Medicine Weill Cornell Medicine New York New York USA

2. Department of Psychiatry and Behavioral Sciences Duke University Durham North Carolina USA

3. Institute of Computational Biology Helmholtz Zentrum München—German Research Center for Environmental Health Neuherberg Germany

4. Department of Neuroscience Mayo Clinic Florida Jacksonville Florida USA

5. Department of Health Sciences Research Mayo Clinic Florida Jacksonville Florida USA

6. Goizueta Alzheimer's Disease Research Center Emory University Atlanta Georgia USA

7. Department of Biochemistry Emory School of Medicine Jacksonville Florida USA

8. Department of Neurology Mayo Clinic Florida Jacksonville Florida USA

9. Rush Alzheimer's Disease Center Rush University Medical Center Chicago Illinois USA

10. Department of Psychiatry and Behavioral Sciences Duke Institute for Brain Sciences and Department of Medicine Duke University Durham North Carolina USA

Funder

National Institutes of Health

National Institute on Aging

National Institute of Neurological Disorders and Stroke

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12714

Reference95 articles.

1. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic

2. Protein aggregation and neurodegenerative disease

3. Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome

4. Metabolic network failures in Alzheimer's disease: A biochemical road map

5. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AutoFocus: a hierarchical framework to explore multi-omic disease associations spanning multiple scales of biomolecular interaction;Communications Biology;2024-09-06

2. Bridging the gap: Multi‐omics profiling of brain tissue in Alzheimer's disease and older controls in multi‐ethnic populations;Alzheimer's & Dementia;2024-08-30

3. Peripheral inflammation is associated with brain atrophy and cognitive decline linked to mild cognitive impairment and Alzheimer’s disease;Scientific Reports;2024-07-29

4. Multi‐omics analyses highlight molecular differences between clinical and neuropathological diagnoses in Alzheimer's disease;European Journal of Neuroscience;2024-07-28

5. Essential New Complexity-Based Themes for Patient-Centered Diagnosis and Treatment of Dementia and Predementia in Older People: Multimorbidity and Multilevel Phenomenology;Journal of Clinical Medicine;2024-07-18